In a firm rebuttal to allegations that Indian pharmaceutical companies replicate products developed by Swiss firms, Commerce and Industry Minister Piyush Goyal has categorically dismissed such claims as unfounded. Emphasizing India’s commitment to intellectual property rights, Goyal underscored the nation’s legal safeguards against unethical patent extensions and highlighted India’s refusal to tolerate “evergreening” of patents.